Elementis

Elementis is a publicly traded UK specialty chemicals company that supplies performance additives and ingredients across personal care, coatings, plastics, construction, and selected pharmaceutical applications. In healthcare-related markets, the company operates a pharma ingredients business focused on commercial antacid raw materials, tabletting excipients, and rheological additives used in pharmaceutical and cosmetic formulations. Its pharma offering includes aluminium and magnesium-based antacid compounds, synthetic calcium sulfate excipients, and hydrotalcite-based gel systems, all positioned as GMP-certified products for formulators and manufacturers. Elementis is not a therapeutic drug developer and does not appear to run a clinical pipeline; rather, it is a commercial supplier of specialty ingredients and formulation components. The broader group has approximately 1,000 employees globally, is listed on the London Stock Exchange, and is executing its "Elevate Elementis" strategy as a pure-play specialty chemicals business.